Evidence map›Paper›PMID 34149688›Full record

Trial reportFrontiers in immunology2021

Immunological Impact of a Gluten-Free Dairy-Free Diet in Children With Kidney Disease: A Feasibility Study.

María José Pérez-Sáez, Audrey Uffing, Juliette Leon, Naoka Murakami, Andreia Watanabe, Thiago J Borges, Venkata S Sabbisetti, Pamela Cureton, Victoria Kenyon, Leigh Keating and 12 more

Erratum issuedOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 9 institutions in 3 countries.

María José Pérez-SáezRenal Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, United States.
Audrey UffingRenal Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, United States.
Juliette LeonRenal Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, United States.
Naoka MurakamiRenal Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, United States.
Andreia WatanabeDepartment of Pediatrics, Pediatric Nephrology Unit, Instituto da Criança, Hospital das Clínicas - University of São Paulo Medical School (USP), São Paulo, Brazil.
Thiago J BorgesRenal Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, United States.
Venkata S SabbisettiRenal Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, United States.
Pamela CuretonCenter for Celiac Research and Treatment, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA, United States.
Victoria KenyonCenter for Celiac Research and Treatment, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA, United States.
Leigh KeatingExperimental Therapeutics/Interventional Trials Center, Boston Children's Hospital, Boston, MA, United States.
Karen YeeCenter for Clinical Investigation, Brigham & Women's Hospital, Boston, MA, United States.
Carla Aline Fernandes SatiroDivision of Nutrition, Instituto da Criança, Hospital das Clínicas - University of Sao Paulo Medical School, Sao Paulo, Brazil.
Gloria SerenaCenter for Celiac Research and Treatment, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA, United States.
Friedhelm HildebrandtDepartment of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
Cristian V RiellaRenal Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Towia A LibermannBeth Israel Deaconess Medical Center Genomics, Proteomics, Bioinformatics and Systems Biology Center, Division of Interdisciplinary Medicine and Biotechnology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Minxian WangMedical and Population Genetics Program, Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.
Julio PascualServicio de Nefrología, Hospital del Mar, Barcelona, Spain.
Joseph V BonventreRenal Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, United States.
Paolo CravedilRenal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Alessio FasanoCenter for Celiac Research and Treatment, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA, United States.
Leonardo V RiellaRenal Division, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, United States.
Harvard University · USBrigham and Women's Hospital · USMassachusetts General Hospital · USHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRBeth Israel Deaconess Medical Center · USBoston Children's Hospital · USBroad Institute · USHospital Del Mar · ESIcahn School of Medicine at Mount Sinai · US

Funding

Identification and function of new genes causing childhood nephrotic syndromeR01DK076683 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HILDEBRANDT, FRIEDHELM · 2007 to 2021
$5.3M
Protection of kidney from autoimmunity by modulating co-stimlatory signalingK08DK120868 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI MURAKAMI, NAOKA · 2019 to 2023
$886k
NIDDK NIH HHS K08 DK120868NIDDK NIH HHS R01 DK076683
6 · The paper itself

Abstract

Kidney disease affects 10% of the world population and is associated with increased mortality. Steroid-resistant nephrotic syndrome (SRNS) is a leading cause of end-stage kidney disease in children, often failing standard immunosuppression. Here, we report the results of a prospective study to investigate the immunological impact and safety of a gluten-free and dairy-free (GF/DF) diet in children with SRNS. The study was organized as a four-week summer camp implementing a strict GF/DF diet with prospective collection of blood, urine and stool in addition to whole exome sequencing WES of DNA of participants. Using flow cytometry, proteomic assays and microbiome metagenomics, we show that GF/DF diet had a major anti-inflammatory effect in all participants both at the protein and cellular level with 4-fold increase in T regulatory/T helper 17 cells ratio and the promotion of a favorable regulatory gut microbiota. Overall, GF/DF can have a significant anti-inflammatory effect in children with SRNS and further trials are warranted to investigate this potential dietary intervention in children with SRNS.

Indexed as

Diet, Gluten-FreeAdolescentBiomarkersChildChild, PreschoolCytokinesDairy ProductsFeasibility StudiesFemaleGastrointestinal MicrobiomeHumansInfantInflammation MediatorsIntestinesMaleNephrotic SyndromeBiomarkersCytokinesInflammation Mediatorsdairy-freedietgluten-freeinflammationsteroid resistance nephrotic syndrome

Identifiers

PMID34149688
PMCPMC8208082
OpenAlexW3167917450

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.